Is serum β2-microglobulin a tumor marker in gastrointestinal cancer?
- 1 October 1980
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 106 (3) , 309-317
- https://doi.org/10.1016/0009-8981(80)90315-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancerThe American Journal of Surgery, 1978
- Serum β2-microglobulin in controls and cancer patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Carcinoembryonales Antigen (CEA)Deutsche Medizinische Wochenschrift (1946), 1977
- Patterns of serial CEA assays and their clinical use in management of colorectal cancerJournal of Surgical Oncology, 1976
- Carcinoembryonic Antigen in Management of Colorectal CarcinomaBMJ, 1974
- DETECTION OF RECURRENCE OF LARGE-BOWEL CARCINOMA BY RADIOIMMUNOASSAY OF CIRCULATING CARCINOEMBRYONIC ANTIGEN (C.E.A.)The Lancet, 1974
- Beta2-Mikroglobulin im Serum — ein Parameter des Glomerulumfiltrates*Deutsche Medizinische Wochenschrift (1946), 1974
- Serum β2-microglobulin in various disordersClinica Chimica Acta; International Journal of Clinical Chemistry, 1973
- Serum β2-Microglobulin in Renal DiseaseNephron, 1973
- DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUESThe Journal of Experimental Medicine, 1965